1982
DOI: 10.1038/298757a0
|View full text |Cite
|
Sign up to set email alerts
|

Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

10
92
1

Year Published

1984
1984
2007
2007

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 279 publications
(103 citation statements)
references
References 21 publications
10
92
1
Order By: Relevance
“…In our laboratory slight effects of N-methyl D-aspartate (NMDA) and quisqualate on glutamate release, which have also been reported by Sherman et al (1992), did not respond to established antagonists of NMDA and 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors (McMahon et al, 1989). Presynaptic effects of kainate (Ferkany and Coyle, 1982) can be accounted for by its ability to inhibit the acidic amino acid transporter , although a G-proteincoupled action of kainate has also been proposed (Brammer et al, 1991).…”
Section: The Acute Regulation Of Glutamate Exocytosismentioning
confidence: 94%
“…In our laboratory slight effects of N-methyl D-aspartate (NMDA) and quisqualate on glutamate release, which have also been reported by Sherman et al (1992), did not respond to established antagonists of NMDA and 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors (McMahon et al, 1989). Presynaptic effects of kainate (Ferkany and Coyle, 1982) can be accounted for by its ability to inhibit the acidic amino acid transporter , although a G-proteincoupled action of kainate has also been proposed (Brammer et al, 1991).…”
Section: The Acute Regulation Of Glutamate Exocytosismentioning
confidence: 94%
“…The central effect of kainate appears to propagate through an increase in the release of glutamate and aspartate after activation of presynaptic kainate receptors, depolarization after activation of postsynaptic a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)/kainate receptors, and the secondary activation of N-methyl-d-aspartate (NMDA) receptors. 12,24 In support of this, NMDA antagonists as well as AMPA/kainate antagonists were reported to attenuate kainate-induced neuronal death and seizure activity. 6,8,9,11,22 Several studies suggest that kainate neurotoxicity may be mediated through down-regulation of glutamate receptor subunit 2 expression in the degenerating hippocampal areas, 14,32 which is expected to enhance Ca 2Ï© permeability through non-NMDA receptors and trigger neuronal death.…”
mentioning
confidence: 85%
“…L-[G-3H]Glutamic acid of specific radioactivity of [29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45] Ci/mmol (1 Ci = 37 GBq) was purchased from Amersham. Triton X-100 (gas chromatographic grade) and the L and D isomers of glutamic and aspartic acids were obtained from Merck; NMeAsp, quinolinic, and kainic acids, from Sigma; quisqualic, ibotenic, DL-2-amino-5-phosphonovaleric (DL-APV), and DL-2-amino-7-phosphonoheptanoic (DL-APH) acids, from Cambridge Research Biochemicals (Harston, U.K.); and DL-2-amino-3-phosphonopropionic acid and DL-APB, from Calbiochem (La Jolla, CA).…”
mentioning
confidence: 99%